Article
Pharma In Brief - Blinded Expert Evidence Favoured: Court Dismisses PM(NOC) Application For Ciclesonide
The 322 Patent claims compositions of ciclesonide with varying osmotic pressures, ranging from 10 mOsm or less to 290 mOsm or less.
Norton Rose Fulbright Canada LLP
